The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 02, 2018

Filed:

Apr. 15, 2015
Applicant:

The University of Hong Kong, Hong Kong, CN;

Inventors:

Zhongjun Zhou, Hong Kong, CN;

Baohua Liu, Hong Kong, CN;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/16 (2006.01); A61K 38/17 (2006.01); C12Q 1/37 (2006.01); C12Q 1/34 (2006.01); A61K 31/05 (2006.01); G01N 33/573 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1709 (2013.01); A61K 31/05 (2013.01); A61K 38/16 (2013.01); C12Q 1/34 (2013.01); C12Q 1/37 (2013.01); G01N 33/573 (2013.01); G01N 2333/47 (2013.01); G01N 2333/91142 (2013.01); G01N 2333/98 (2013.01); G01N 2500/02 (2013.01); G01N 2500/04 (2013.01); G01N 2500/10 (2013.01);
Abstract

In one embodiment, the present invention provides methods of modulating the deacetylase activity of SIRT1 in one or more cell by modifying the binding affinity of lamin A to SIRT1 via one or more interaction modifying compound. In another embodiment, the present invention provides methods of screening SIRT1-activating/inhibiting compounds based on the interaction between lamin A and SIRT1 proteins and SIRT1-activating property of lamin A. In another embodiment, the present invention provides uses of SIRT1-activating compounds to treat patient(s) suffering from metabolic and/or aging-related degenerative diseases, and uses of SIRT1-inhibiting compounds to treat human malignancies.


Find Patent Forward Citations

Loading…